Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mark Vartanian"'
Autor:
Hajar Samadian, Rachel L. Merzel, Jennifer M. Dyson, Junjie Chen, Carolina Frey, Alexis Jones, Mark Vartanian, Brent B. Ward, Mark M. Banaszak Holl
Publikováno v:
Molecular Pharmaceutics. 19:843-852
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f600695c9af5920d53ab4b5fe5db11
https://doi.org/10.1021/acs.molpharmaceut.1c00794
https://doi.org/10.1021/acs.molpharmaceut.1c00794
Autor:
Hajar, Samadian, Rachel L, Merzel, Jennifer M, Dyson, Junjie, Chen, Carolina, Frey, Alexis, Jones, Mark, Vartanian, Brent B, Ward, Mark M, Banaszak Holl
Publikováno v:
Molecular pharmaceutics. 19(3)
Folate receptor (FR) overexpression in a wide range of solid tumors provides an opportunity to develop novel, targeted cancer therapeutics. In this study, we investigated whether prebinding the chemotherapeutic methotrexate (MTX) to folate-binding pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6629f6b4731c2f42065f52803fdf0e2a
https://pubmed.ncbi.nlm.nih.gov/35133169
https://pubmed.ncbi.nlm.nih.gov/35133169
Autor:
Jack L, Martin, Neil, Gottehrer, Harvey, Zalesin, Paul T, Hoff, Michael, Shaw, James Hw, Clarkson, Pam, Haan, Mark, Vartanian, Terry, McLeod, Stephen M, Swanick
Publikováno v:
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995). 36(5)
Oral squamous cell cancer (OSCC) is often diagnosed in late stages. Informative biomarkers could play a key role in early diagnosis. Prior case-control studies identified discriminatory salivary mRNA markers for OSCC. The National Cancer Institute (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1367e7ef0bf5b330286bb84f48be7805
https://pubmed.ncbi.nlm.nih.gov/26053640
https://pubmed.ncbi.nlm.nih.gov/26053640
Autor:
Alina Kotlyar, Baohua Huang, Pascale R. Leroueil, Thommey P. Thomas, Mark Vartanian, James R. Baker, Ankur Desai, Hong Zong, Brent B. Ward, Abraham F. L. Van Der Spek, Xiangyang Shi, Xue-Min Cheng
Publikováno v:
Pharmaceutical research. 30(1)
Design and evaluate the in vitro and in vivo efficacy of two extended release morphine formulations developed for IV administration by complexing esterase activated morphine prodrugs to surface-modified, generation 5 (G5) poly(amidoamine) (PAMAM) den
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29f0c6033ffea7abddf32e9247e35dc
https://pubmed.ncbi.nlm.nih.gov/23054086
https://pubmed.ncbi.nlm.nih.gov/23054086